Search

Displaying results 5381 - 5390 of 10000 in total
  1. Drug

    Black-eyed pea

    go.drugbank.com/drugs/DB10663
    Approved

    Black-eyed pea allergenic extract is used in allergenic testing.

  2. Drug

    Grain mill dust

    go.drugbank.com/drugs/DB10869
    Approved

    Grain mill dust allergenic extract is used in allergenic testing.

  3. Drug

    Quercus muehlenbergii pollen

    go.drugbank.com/drugs/DB10886
    Approved

    Quercus muehlenbergii pollen allergenic extract is used in allergenic testing.

  4. Drug

    Tanacetum cinerariifolium flower

    go.drugbank.com/drugs/DB10975
    Approved

    Tanacetum cinerariifolium flower allergenic extract is used in allergenic testing.

  5. Drug

    Betula pendula pollen

    go.drugbank.com/drugs/DB11004
    Approved

    Betula pendula pollen allergenic extract is used in allergenic testing.

  6. Drug

    Parkinsonia florida pollen

    go.drugbank.com/drugs/DB11006
    Approved

    Parkinsonia florida pollen allergenic extract is used in allergenic testing.

  7. Drug

    Cavia porcellus dander

    go.drugbank.com/drugs/DB11019
    Approved

    Cavia porcellus dander allergenic extract is used in allergenic testing.

  8. Drug

    RO-6870810

    go.drugbank.com/drugs/DB15151
    Investigational

    RO-6870810 is under investigation in clinical trial NCT02308761 (A Study of RO6870810/TEN-010 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndrome).

    Synonyms: 2-[(4S)-6-(4-chlorophenyl)-1,7,8-trimethylthiophenol[3,2-f]1,2,4-triazolo[4,3-a]1,4-diazepin-4-yl]-N-[3-(4-methylpiperazinyl)propyl]acetamide, 6H-THIENO(3,2-F)(1,2,4)TRIAZOLO(4,3-A)(1,4)DIAZEPINE-6-ACETAMIDE, 4-(4-CHLOROPHENYL)-2,3,9-TRIMETHYL-N-(3-(4-METHYL-1-PIPERAZINYL)PROPYL)-, (6S)-
  9. Drug

    Pimodivir

    go.drugbank.com/drugs/DB14974
    Investigational

    Pimodivir is under investigation in clinical trial NCT02658825 (A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy Participants).

  10. Drug

    Olvimulogene nanivacirepvec

    go.drugbank.com/drugs/DB16268
    Investigational

    Olvimulogene nanivacirepvec is under investigation in clinical trial NCT01443260 (A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis).